For many complex surgical operations, research concludes that patients who seek care from a surgeon who performs a high number of such procedures (high-volume surgeons) have lower mortality rates than patients operated on by low-volume surgeons. As a health economist, I was interested in learning whether health care costs differ between high- and low-volume surgeons. Are the costs of a hospital stay for an operation performed by a high-volume surgeon higher than that for a low-volume surgeon? After all, customers often assume that price is a signal of quality.
Several years ago, I and Thomas Aloia, a surgeon at the M.D. Anderson Cancer Center, analyzed hospital discharge records for patients who underwent six complex cancer operations (ranging from colon resection to pancreatic resection) in the states of Florida, New Jersey, and New York between 1989 and 2000. We found that the cost of hospital stays for patients who were operated on by a high-volume surgeon were significantly lower than for surgeons who performed a small number of cancer operations each year. However, we did not know the underlying reason why this relationship existed.
Dr. Aloia and I were awarded an NIH grant to find out why higher volume surgeons were able to achieve lower health care costs. We published three papers from this grant, with the final paper providing the most illuminating results. Analyzing Medicare data from 2005 through 2009, we found that higher surgeon volume was associated with lower-cost hospital stays for four cancer operations: colectomy, rectal resection, pulmonary lobectomy, and pancreatic resection.
The largest cost savings occurred for pancreatic resection, which is the most complicated operation. Patients operated on by a surgeon in the 95th percentile for procedure volume (14 operations per year) had costs that were on average $3,286 lower than a surgeon in the 5th percentile (1 pancreatic resection per year). For the operation that is considered more straightforward, a colectomy, costs for the highest volume surgeons were $1,089 lower than for the lowest volume physicians.
In this study, we were able to identify the source of the cost differential. Patients treated by high-volume surgeons had fewer instances of “processes of care” that are commonly used to address complications. These processes, including total parenteral nutrition, and critical care and inpatient consultations, raise the costs of a hospital stay between 14 and 34 percent. In fact, the higher need to deliver these processes of care to patients operated on by low-volume surgeons explained all of the volume-cost differential for colectomy and roughly half the difference for pancreatic resection.
Our analysis suggests that in the case of cancer surgery, higher price is not necessarily a signal of high quality. Instead, it may be an indicator of the need for costly care to address post-surgical complications. Patients may be better off seeking care from higher volume surgeons, not just because it’s better for their pocketbooks, but because they will receive better care.
What do these results suggest for health care policy? Most physicians are currently reimbursed under the fee-for-service system. Whether or not a surgeon performs an operation well or poorly, the fee the doctor receives from Medicare (or private insurers) remains the same. And if lower quality leads to more complications, then other physicians also receive additional compensation to address the resulting health care issues.
The Center for Medicare and Medicaid Services is gradually moving away from fee-for-service payments and towards value-based care. Providing a “bundled payment” to doctors and hospitals, where Medicare specifies a fixed reimbursement rate for all care associated with a treatment regardless of the actual costs of the hospital stay, will incentivize providers to deliver care with fewer costly complications.
However, efforts to make bundled payments mandatory for joint replacement and some cardiac care have been stalled by Health and Human Services Secretary Tom Price. Nevertheless, CMS has been able to launch an Oncology Care Model, which introduces financial and performance accountability measures for many physician practices delivering chemotherapy to Medicare beneficiaries across the country. We are still awaiting to learn the results of this new model.
Our nation has spent the last few months in a tumultuous debate over who should and should not receive government-subsidized health insurance. Yet health insurance coverage has become so costly, because we have failed to focus on the factors that needlessly drive up costs in our health care system. We must change the way we reimburse and incentivize health care providers for the care that they deliver. Bundled payments and other types of value-based care are potentially powerful tools for simultaneously improving the quality of patient care and reducing healthcare spending. Only with such tools will we be able to achieve a sustainable health care system.
Dr. Vivian Ho is a member of the Texas Medical Center Health Policy Institute’s Executive Advisory Committee. Dr. Ho is the James A. Baker III Institute Chair in Health Economics at Rice University and the Director of the Center for Health and Biosciences at Rice University’s Baker Institute for Public Policy.
Our new white paper offers EIGHT solutions for reducing the cost of health care. Are there any you'd add to the list? Read our report and let us know your suggestions below.
Our new white paper offers EIGHT solutions for reducing the cost of health care. Are there any you'd add to the list? Read our report & let us know your suggestions. #healthpolicy https://t.co/cOw6oJSbXh CC @TXMedCenter https://t.co/5et1BuiLtH
Our latest op-ed in The Hill says that if lawmakers don't act soon, ERs across the country will be overwhelmed by patients -- and some may even turn them away. Find out why.
"If Congress doesn’t fix health care, emergency departments will soon be a mess" Our latest from @thehill https://t.co/DwX2jl9rUY #healthpolicy https://t.co/W9Udsy1Sf7
Our next big event is 4/10 in Houston. Join us as we debate and discuss "what's next for U.S. health care." Featuring experts from @txwomans @UTexasSPH @MDAndersonNews @UHouston @HarrisHealth @TXMedCenter Best of all, it's free. https://t.co/xr7AK63C74 https://t.co/aM6WNZlX2T
Our next big event is April 10 in Houston. Please join us as we debate and discuss "what's next for U.S. health care." Featuring experts from Texas Woman's University UTHealth School of Public Health MD Anderson Cancer Center Harris Health System University of Houston and Texas Medical Center. Best of all, it's free.
You can livestream our weekly health policy course at https://t.co/Hg24jPlIai This week we're covering social determinants of health #TMCPolicyCourse https://t.co/xMNAW8aYly
The US spends $1,000 per person per year on retail pharmaceuticals. That’s more than double UK spending and 50 percent more than spending in Canada and Germany. What's the fix? Here's 5 ideas. https://t.co/juJvsS0ocp @TXMedCenter #healthpolicy https://t.co/muFWfn1J1h
Join us for our next big panel discussion, "U.S. Health Care: Where Do We Go Next?" 4/10 at @TXMedCenter. Featuring leaders from @harrishealth @UHouston @UHLAW @UTHealth @UTexasSPH @txwomans. Best of all: it's free. Register https://t.co/NYzvQGrAYi https://t.co/uebOg0pSae
Join us for our next big panel discussion, "U.S. Health Care: Where Do We Go Next?" 4/10 at @TXMedCenter. Featuring leaders from @harrishealth @UHouston @UHLAW @UTHealth @UTexasSPH @txwomans. Best of all: it's free. Register https://t.co/NYzvQGJbPQ https://t.co/WPPlmuJB1C
Join us for our next big panel discussion, "U.S. Health Care: Where Do We Go Next?" 4/10 at @TXMedCenter. Featuring leaders from @harrishealth @UHouston @UHLAW @UTHealth @UTexasSPH @txwomans. Best of all: it's free. Register https://t.co/NYzvQGrAYi https://t.co/aFyfM6UvNp
Tomorrow night, we're hosting another session of our #TMCPolicyCourse with experts from @UHLAW @CHCTexas @Health4Texas & @CGAGroup. Attend in-person or online. Details, registration, and livestream link at https://t.co/Hg24jPlIai https://t.co/OOfS9h6MPZ
Join us for our next big panel discussion, "U.S. Health Care: Where Do We Go Next?" 4/10 at @TXMedCenter. Featuring leaders from @harrishealth @UHouston @UHLAW @UTHealth @UTexasSPH @txwomans. Best of all: it's free. Register https://t.co/NYzvQGJbPQ https://t.co/9yoLn9qato
RT @HealthyTexans: ICYMI: important news and insights from @HealthPolicyTMC https://t.co/fAwWq6dqsz